Clinical Trials

100 enrolled 18 charts

Carcinoma, Hepatocellular

NCT00520975 2025-03-28

Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU

96 enrolled 16 charts

Breast Neoplasms

NCT01167725 2024-12-27

Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer

340 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT04325698 2024-10-01

A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC

8 enrolled 6 charts

Thoracic

Advanced Non-squamous NSCLC

NCT01303679 2023-09-06

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

117 enrolled

First Line Metastatic Breast Cancer

NCT00303628 2023-07-06

Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer

355 enrolled 11 charts

Rectal Neoplasms

NCT00946712 2023-05-23

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

1,333 enrolled 22 charts

Thoracic

Adenocarcinoma of Lung

NCT03690739 2022-02-24

Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer

9 enrolled

Gynecologic

Ovarian Neoplasms

NCT00625898 2020-09-10

BETH

3,509 enrolled

Breast Neoplasms

NCT00544700 2020-02-20

Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer

265 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01198158 2019-03-06

Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy

77 enrolled 11 charts

Genitourinary

Carcinoma, Renal Cell

NCT02162537 2019-02-01

METAL2

95 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01279681 2017-12-08

Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

32 enrolled 14 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

NCT00324987 2017-09-14

S0502

12 enrolled 13 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00486759 2017-07-25

A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

787 enrolled 8 charts

Lymphoid

Lymphoma, B-Cell

NCT00720512 2015-03-11

BEBYP

184 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00499369 2014-07-31

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

72 enrolled 15 charts

Colonic Neoplasms, Rectal Neoplasms

NCT01200212 2013-05-22

TABEA

432 enrolled

Breast Neoplasms

NCT00070122 2013-01-25

Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer

2,200 enrolled